文献速递关节外科

50岁以下患者使用高交联聚乙烯全髋关节置换术的最小10年结局:系统综述与Meta分析

Minimum 10-Year Outcomes of Total Hip Arthroplasty With Highly Cross-Linked Polyethylene in Patients Under 50 Years: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2025-12-16

本系统综述与Meta分析纳入18项研究共1587髋,评估50岁以下患者使用高交联聚乙烯行全髋关节置换术、随访至少10年的结局,加权平均随访14.1年。总体无翻修生存率为98%,Harris髋关节评分加权平均改善43.7分,随机效应Meta分析合并线性磨损率为0.024 mm/年(95%CI:0.013至0.035),所有磨损率均远低于与骨溶解风险相关的0.1 mm/年阈值,且不受股骨头承重材料或尺寸影响。作者认为这些发现支持在年轻患者中继续使用高交联聚乙烯以最大化磨损参数和无翻修生存。

要点

  • 50岁以下患者高交联聚乙烯全髋关节置换术后总体无翻修生存率为98%。
  • Harris髋关节评分加权平均改善43.7分,合并线性磨损率为0.024 mm/年(95%CI:0.013至0.035)。
  • 所有磨损率均远低于0.1 mm/年骨溶解风险阈值,不受股骨头材料或尺寸影响。

核心结论

  • 50岁及以下患者使用高交联聚乙烯行全髋关节置换术,术后随访至20年可获得优异的临床和影像学结局,磨损极小。
  • 这些获益在很大程度上不受股骨头承重材料或尺寸影响,作者认为支持在年轻患者中继续使用高交联聚乙烯以最大化磨损参数和无翻修生存。

研究设计与样本

  • 遵循PRISMA指南的系统综述与Meta分析,检索Embase、Ovid Medline、Scopus和Cochrane数据库。
  • 纳入标准为50岁以下患者、使用高交联聚乙烯行全髋关节置换术、报告原始数据且平均随访≥10年的研究。
  • 共纳入18项研究(n=1587髋),加权平均随访14.1年;两名评价者独立提取数据,采用MINORS标准评估研究质量,并进行多项随机效应Meta分析。

主要发现

  • 总体无翻修生存率为98%。
  • Harris髋关节评分加权平均改善43.7分。
  • 随机效应Meta分析合并线性磨损率为0.024 mm/年(95%CI:0.013至0.035)。
  • 所有磨损率均远低于与骨溶解风险相关的0.1 mm/年阈值,无论股骨头承重材料或尺寸如何。

关键数值与推荐

  • 纳入标准:患者年龄<50岁,使用高交联聚乙烯行全髋关节置换术,平均随访≥10年。
  • 无翻修生存率98%;Harris髋关节评分加权平均改善43.7分;合并线性磨损率0.024 mm/年(95%CI:0.013至0.035)。
  • 磨损率阈值:0.1 mm/年(与骨溶解风险相关),所有磨损率均低于该阈值。
  • 研究质量评估采用MINORS标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total hip arthroplasty (THA) is increasing in utilization among young patients. While THA markedly improves outcomes in those who have degenerative hip disease, patients under 50 years face an extended lifetime risk for complications and revisions. Highly cross-linked polyethylene (HXLPE) is associated with reduced wear, revision rates, and osteolysis compared to conventional polyethylene, potentially enhancing implant longevity in this younger, active population. This study systematically reviewed and meta-analyzed the outcomes of THA using HXLPE in patients under 50 years of age at a minimum 10-year follow-up. METHODS: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Searches were performed in Embase, Ovid Medline, Scopus, and Cochrane databases. Inclusion criteria targeted studies with patients under 50 years reporting original data on THA using HXLPE with a mean follow-up of ≥ 10 years. Data extraction was performed independently by two reviewers, and study quality was evaluated using the Methodological Index for Non-Randomized Studies (MINORS) criteria. Multiple random-effects meta-analyses were performed to summarize outcomes. There were 18 studies included (n = 1,587 hips) with a weighted mean follow-up of 14.1 years. RESULTS: Overall, revision-free survivorship was 98%, and the weighted mean improvement in Harris Hip Score was 43.7 points. A random-effects meta-analysis yielded a pooled linear wear rate of 0.024 mm/year (95% confidence interval [CI]: 0.013 to 0.035). All wear rates remained well below the 0.1 mm/year threshold associated with osteolysis risk, regardless of femoral bearing material or size. CONCLUSIONS: Total hip arthroplasty using HXLPE in patients aged ≤ 50 years yields excellent clinical and radiographic outcomes with minimal wear observed up to 20 years postoperatively. Importantly, these benefits are largely maintained regardless of the femoral head bearing material or size. These findings support the continued use of HXLPE among young patients to maximize wear parameters and revision-free survival.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Randall ZD, Mologne MS, Gaziano DJ, et al. Minimum 10-Year Outcomes of Total Hip Arthroplasty With Highly Cross-Linked Polyethylene in Patients Under 50 Years: A Systematic Review and Meta-Analysis. J Arthroplasty. 2025. PMID: 41412352. doi:10.1016/j.arth.2025.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。